{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:05:44Z","timestamp":1789477544912,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170180"],"award-info":[{"award-number":["82170180"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"DOI":"10.1186\/s40164-026-00829-6","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:17:54Z","timestamp":1789474674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dysregulated KMT2D mutant targeting immunogenic rewiring to overcome epigenetic entropy promotes follicular lymphomagenesis"],"prefix":"10.1186","volume":"15","author":[{"given":"Yuqian","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manman","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"1","key":"829_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41572-019-0132-x","volume":"5","author":"A Carbone","year":"2019","unstructured":"Carbone A, Roulland S, Gloghini A, Younes A, von Keudell G, L\u00f3pez-Guillermo A, et al. Follicular lymphoma. Nat Rev Dis Primers. 2019;5(1):83.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"829_CR2","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41590-018-0181-4","volume":"19","author":"P Milpied","year":"2018","unstructured":"Milpied P, Cervera-Marzal I, Mollichella ML, Tesson B, Brisou G, Traverse-Glehen A, et al. Human germinal center transcriptional programs are de-synchronized in B cell lymphoma. Nat Immunol. 2018;19(9):1013\u201324.","journal-title":"Nat Immunol"},{"issue":"1","key":"829_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.beha.2017.10.006","volume":"31","author":"T Lackraj","year":"2018","unstructured":"Lackraj T, Goswami R, Kridel R. Pathogenesis of follicular lymphoma. Best Pract Res Clin Haematol. 2018;31(1):2\u201314.","journal-title":"Best Pract Res Clin Haematol"},{"key":"829_CR4","doi-asserted-by":"crossref","unstructured":"Brisou G, Baaklini S, Mossadegh-Keller N, Beyou A, Zala M, Gil L et al. Emergence of highly-plastic B cell states cooperates with early immune microenvironment remodeling to drive follicular lymphomagenesis. Blood. 2023; 142.","DOI":"10.1182\/blood-2023-185829"},{"issue":"11","key":"829_CR5","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1182\/blood.2020010263","volume":"139","author":"C Casulo","year":"2022","unstructured":"Casulo C, Dixon JG, Le-Rademacher J, Hoster E, Hochster HS, Hiddemann W, et al. Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials. Blood. 2022;139(11):1684\u201393.","journal-title":"Blood"},{"issue":"1","key":"829_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13045-022-01326-z","volume":"15","author":"L Liu","year":"2022","unstructured":"Liu L, Yu X, Li Z, He X, Zha J, Lin Z, et al. Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry. J Hematol Oncol. 2022;15(1):115.","journal-title":"J Hematol Oncol"},{"issue":"34","key":"829_CR7","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1200\/JCO.18.02365","volume":"37","author":"JWD Tobin","year":"2019","unstructured":"Tobin JWD, Keane C, Gunawardana J, Mollee P, Birch S, Hoang T, et al. Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration. J Clin Oncol. 2019;37(34):3300\u20139.","journal-title":"J Clin Oncol"},{"issue":"8","key":"829_CR8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1182\/blood-2016-05-717355","volume":"128","author":"V Jurinovic","year":"2016","unstructured":"Jurinovic V, Kridel R, Staiger AM, Szczepanowski M, Horn H, Dreyling MH, et al. Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy. Blood. 2016;128(8):1112\u201320.","journal-title":"Blood"},{"issue":"7","key":"829_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41408-021-00521-4","volume":"11","author":"P Mondello","year":"2021","unstructured":"Mondello P, Fama A, Larson MC, Feldman AL, Villasboas JC, Yang ZZ, et al. Lack of intrafollicular memory CD4\u2009+\u2009T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma. Blood Cancer J. 2021;11(7):130.","journal-title":"Blood Cancer J"},{"issue":"1","key":"829_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40164-024-00479-6","volume":"13","author":"J Liu","year":"2024","unstructured":"Liu J, Jiang P, Lu Z, Yu Z, Qian P. Decoding leukemia at the single-cell level: clonal architecture, classification, microenvironment, and drug resistance. Exp Hematol Oncol. 2024;13(1):12.","journal-title":"Exp Hematol Oncol"},{"issue":"10","key":"829_CR11","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/nm.3940","volume":"21","author":"J Zhang","year":"2015","unstructured":"Zhang J, Dominguez-Sola D, Hussein S, Lee JE, Holmes AB, Bansal M, et al. Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis. Nat Med. 2015;21(10):1190\u20138.","journal-title":"Nat Med"},{"issue":"10","key":"829_CR12","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/nm.3943","volume":"21","author":"A Ortega-Molina","year":"2015","unstructured":"Ortega-Molina A, Boss IW, Canela A, Pan H, Jiang Y, Zhao C, et al. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development. Nat Med. 2015;21(10):1199\u2013208.","journal-title":"Nat Med"},{"issue":"1","key":"829_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-024-00543-1","volume":"13","author":"S Zheng","year":"2024","unstructured":"Zheng S, Wang W, Shen L, Yao Y, Xia W, Ni C. Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies. Exp Hematol Oncol. 2024;13(1):80.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"829_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41392-020-00437-8","volume":"6","author":"YH Huang","year":"2021","unstructured":"Huang YH, Cai K, Xu PP, Wang L, Huang CX, Fang Y, et al. CREBBP\/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2\/CSF1 axis. Signal Transduct Target Ther. 2021;6(1):10.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"829_CR15","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.7150\/ijbs.93349","volume":"20","author":"QX Liu","year":"2024","unstructured":"Liu QX, Zhu Y, Yi HM, Shen YG, Wang L, Cheng S, et al. KMT2D mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-induced regulatory T cell trafficking via FBXW7-NOTCH-MYC\/TGF-\u03b21 axis. Int J Biol Sci. 2024;20(10):3972\u201385.","journal-title":"Int J Biol Sci"},{"issue":"20","key":"829_CR16","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375\u201390.","journal-title":"Blood"},{"key":"829_CR17","doi-asserted-by":"publisher","first-page":"1036844","DOI":"10.3389\/fphar.2022.1036844","volume":"13","author":"H Jang","year":"2022","unstructured":"Jang H, Park Y, Jang J. Serum and glucocorticoid-regulated kinase 1: Structure, biological functions, and its inhibitors. Front Pharmacol. 2022;13:1036844.","journal-title":"Front Pharmacol"},{"key":"829_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.theriogenology.2023.02.001","volume":"200","author":"J Wang","year":"2023","unstructured":"Wang J, Wang L, Wang Z, Lv M, Fu J, Zhang Y, et al. Vitamin C down-regulates the H3K9me3-dependent heterochromatin in buffalo fibroblasts via PI3K\/PDK1\/SGK1\/KDM4A signal axis. Theriogenology. 2023;200:114\u201324.","journal-title":"Theriogenology"},{"issue":"2","key":"829_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cell.2022.12.017","volume":"186","author":"X Liu","year":"2023","unstructured":"Liu X, Liu Z, Wu Z, Ren J, Fan Y, Sun L, et al. Resurrection of endogenous retroviruses during aging reinforces senescence. Cell. 2023;186(2):287\u2013e304226.","journal-title":"Cell"},{"issue":"1","key":"829_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41392-023-01626-x","volume":"8","author":"Y Fang","year":"2023","unstructured":"Fang Y, Zhang MC, He Y, Li C, Fang H, Xu PP, et al. Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma. Signal Transduct Target Ther. 2023;8(1):381.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"829_CR21","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.devcel.2022.05.004","volume":"57","author":"Z Liu","year":"2022","unstructured":"Liu Z, Ji Q, Ren J, Yan P, Wu Z, Wang S, et al. Large-scale chromatin reorganization reactivates placenta-specific genes that drive cellular aging. Dev Cell. 2022;57(11):1347\u2013e681312.","journal-title":"Dev Cell"},{"issue":"1","key":"829_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"10","key":"829_CR23","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1182\/blood-2012-06-440065","volume":"121","author":"ME Garc\u00eda-Ojeda","year":"2013","unstructured":"Garc\u00eda-Ojeda ME, Klein Wolterink RG, Lema\u00eetre F, Richard-Le Goff O, Hasan M, Hendriks RW, et al. GATA-3 promotes T-cell specification by repressing B-cell potential in pro-T cells in mice. Blood. 2013;121(10):1749\u201359.","journal-title":"Blood"},{"issue":"7","key":"829_CR24","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1084\/jem.191.7.1085","volume":"191","author":"F Radtke","year":"2000","unstructured":"Radtke F, Ferrero I, Wilson A, Lees R, Aguet M, MacDonald HR. Notch1 deficiency dissociates the intrathymic development of dendritic cells and T cells. J Exp Med. 2000;191(7):1085\u201394.","journal-title":"J Exp Med"},{"issue":"7","key":"829_CR25","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1182\/blood-2013-07-512392","volume":"123","author":"M Brodtkorb","year":"2014","unstructured":"Brodtkorb M, Lingj\u00e6rde OC, Huse K, Tr\u00f8en G, Hystad M, Hilden VI, et al. Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma. Blood. 2014;123(7):1051\u20134.","journal-title":"Blood"},{"issue":"8","key":"829_CR26","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.cell.2026.03.005","volume":"189","author":"C Hinterleitner","year":"2026","unstructured":"Hinterleitner C, Goldberg HV, McHugh D, Barthet VJA, Filliol A, Lowe SW. Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise. Cell. 2026;189(8):2357\u201378.","journal-title":"Cell"},{"issue":"3","key":"829_CR27","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.7150\/thno.91119","volume":"14","author":"Y Deng","year":"2024","unstructured":"Deng Y, Chen Q, Yang X, Sun Y, Zhang B, Wei W, et al. Tumor cell senescence-induced macrophage CD73 expression is a critical metabolic immune checkpoint in the aging tumor microenvironment. Theranostics. 2024;14(3):1224\u201340.","journal-title":"Theranostics"},{"issue":"7983","key":"829_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41586-023-06621-4","volume":"622","author":"S Victorelli","year":"2023","unstructured":"Victorelli S, Salmonowicz H, Chapman J, Martini H, Vizioli MG, Riley JS, et al. Apoptotic stress causes mtDNA release during senescence and drives the SASP. Nature. 2023;622(7983):627\u201336.","journal-title":"Nature"},{"issue":"1","key":"829_CR29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41392-023-01624-z","volume":"8","author":"W Ouyang","year":"2023","unstructured":"Ouyang W, Wang S, Yan D, Wu J, Zhang Y, Li W, et al. The cGAS-STING pathway-dependent sensing of mitochondrial DNA mediates ocular surface inflammation. Signal Transduct Target Ther. 2023;8(1):371.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"829_CR30","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1002\/1878-0261.13079","volume":"15","author":"W Gao","year":"2021","unstructured":"Gao W, Huang Z, Duan J, Nice EC, Lin J, Huang C. Elesclomol induces copper-dependent ferroptosis in colorectal cancer cells via degradation of ATP7A. Mol Oncol. 2021;15(12):3527\u201344.","journal-title":"Mol Oncol"},{"issue":"4","key":"829_CR31","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ccell.2020.03.005","volume":"37","author":"H Alam","year":"2020","unstructured":"Alam H, Tang M, Maitituoheti M, Dhar SS, Kumar M, Han CY, et al. KMT2D deficiency impairs super-enhancers to confer a glycolytic vulnerability in lung cancer. Cancer Cell. 2020;37(4):599\u2013e617597.","journal-title":"Cancer Cell"},{"issue":"6586","key":"829_CR32","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254\u201361.","journal-title":"Science"},{"issue":"2","key":"829_CR33","doi-asserted-by":"publisher","first-page":"101913","DOI":"10.1016\/j.xcrm.2024.101913","volume":"6","author":"L Gui","year":"2025","unstructured":"Gui L, Chen K, Yan J, Chen P, Gao WQ, Ma B. Targeting the mevalonate pathway potentiates NUAK1 inhibition-induced immunogenic cell death and antitumor immunity. Cell Rep Med. 2025;6(2):101913.","journal-title":"Cell Rep Med"},{"issue":"1","key":"829_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40164-023-00427-w","volume":"12","author":"X Zheng","year":"2023","unstructured":"Zheng X, Jin X, Ye F, Liu X, Yu B, Li Z, et al. Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy. Exp Hematol Oncol. 2023;12(1):65.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"829_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40164-025-00737-1","volume":"15","author":"L Du","year":"2026","unstructured":"Du L, Zhang Y, Luo J, He C, Lang J, Cao X. Epigenetic and post-translational regulatory networks of ferroptosis in the tumor immune microenvironment. Exp Hematol Oncol. 2026;15(1):11.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"829_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s40164-024-00551-1","volume":"13","author":"PL Zinzani","year":"2024","unstructured":"Zinzani PL, Mu\u00f1oz J, Trotman J. Current and future therapies for follicular lymphoma. Exp Hematol Oncol. 2024;13(1):87.","journal-title":"Exp Hematol Oncol"},{"issue":"21","key":"829_CR37","doi-asserted-by":"publisher","first-page":"7439","DOI":"10.1073\/pnas.82.21.7439","volume":"82","author":"ML Cleary","year":"1985","unstructured":"Cleary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci U S A. 1985;82(21):7439\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"829_CR38","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1182\/blood.2020008743","volume":"138","author":"J Heward","year":"2021","unstructured":"Heward J, Konali L, D\u2019Avola A, Close K, Yeomans A, Philpott M, et al. KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas. Blood. 2021;138(5):370\u201381.","journal-title":"Blood"},{"issue":"2","key":"829_CR39","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ng.2856","volume":"46","author":"J Okosun","year":"2014","unstructured":"Okosun J, B\u00f6d\u00f6r C, Wang J, Araf S, Yang CY, Pan C, et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nat Genet. 2014;46(2):176\u201381.","journal-title":"Nat Genet"},{"issue":"8","key":"829_CR40","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.tips.2021.05.002","volume":"42","author":"X Zhai","year":"2021","unstructured":"Zhai X, Brownell JE. Biochemical perspectives on targeting KMT2 methyltransferases in cancer. Trends Pharmacol Sci. 2021;42(8):688\u201399.","journal-title":"Trends Pharmacol Sci"},{"issue":"17","key":"829_CR41","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1158\/1078-0432.CCR-16-0903","volume":"22","author":"RM Chabanon","year":"2016","unstructured":"Chabanon RM, Pedrero M, Lefebvre C, Marabelle A, Soria JC, Postel-Vinay S. Mutational landscape and sensitivity to immune checkpoint blockers. Clin Cancer Res. 2016;22(17):4309\u201321.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"829_CR42","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ccell.2023.09.004","volume":"41","author":"MC Zhang","year":"2023","unstructured":"Zhang MC, Tian S, Fu D, Wang L, Cheng S, Yi HM, et al. Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial. Cancer Cell. 2023;41(10):1705\u2013e17161705.","journal-title":"Cancer Cell"},{"issue":"5","key":"829_CR43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018;24(5):679\u201390.","journal-title":"Nat Med"},{"issue":"6","key":"829_CR44","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1158\/2159-8290.CD-20-0839","volume":"11","author":"N Kotlov","year":"2021","unstructured":"Kotlov N, Bagaev A, Revuelta MV, Phillip JM, Cacciapuoti MT, Antysheva Z, et al. Clinical and biological subtypes of B-cell lymphoma revealed by microenvironmental signatures. Cancer Discov. 2021;11(6):1468\u201389.","journal-title":"Cancer Discov"},{"issue":"12","key":"829_CR45","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12(12):860\u201375.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"829_CR46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s40164-025-00705-9","volume":"14","author":"Y Wang","year":"2025","unstructured":"Wang Y, Jiang C, Zhou H, Han R. Transforming cancer immunotherapy: integration of distinct immune-based approaches as redefined dual immunotherapy with potential third-sensitizer. Exp Hematol Oncol. 2025;14(1):114.","journal-title":"Exp Hematol Oncol"},{"issue":"7467","key":"829_CR47","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature12624","volume":"501","author":"CE Meacham","year":"2013","unstructured":"Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature. 2013;501(7467):328\u201337.","journal-title":"Nature"},{"issue":"7467","key":"829_CR48","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature12626","volume":"501","author":"MR Junttila","year":"2013","unstructured":"Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013;501(7467):346\u201354.","journal-title":"Nature"},{"issue":"23","key":"829_CR49","doi-asserted-by":"publisher","first-page":"5919","DOI":"10.1158\/0008-5472.CAN-21-1337","volume":"81","author":"C Liu","year":"2021","unstructured":"Liu C, Qiang J, Deng Q, Xia J, Deng L, Zhou L, et al. ALDH1A1 activity in tumor-initiating cells remodels myeloid-derived suppressor cells to promote breast cancer progression. Cancer Res. 2021;81(23):5919\u201334.","journal-title":"Cancer Res"},{"issue":"1","key":"829_CR50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12943-023-01930-8","volume":"23","author":"DX Wang","year":"2024","unstructured":"Wang DX, Long JY, Li RZ, Zhang DL, Liu H, Liu J, et al. Mutation status of the KMT2 family associated with immune checkpoint inhibitors (ICIs) therapy and implicating diverse tumor microenvironments. Mol Cancer. 2024;23(1):15.","journal-title":"Mol Cancer"},{"issue":"1","key":"829_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13045-019-0804-8","volume":"12","author":"L Yang","year":"2019","unstructured":"Yang L, Li A, Lei Q, Zhang Y. Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment. J Hematol Oncol. 2019;12(1):125.","journal-title":"J Hematol Oncol"}],"container-title":["Experimental Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00829-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-026-00829-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00829-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:17:57Z","timestamp":1789474677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40164-026-00829-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["829"],"URL":"https:\/\/doi.org\/10.1186\/s40164-026-00829-6","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in the research involving human participants were approved by the ethics committee of the First Affiliated Hospital of Xiamen University, and informed consent was obtained from all patients for this study in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"95"}}